Evidence map›Paper›PMID 40597623›Full record

ReviewBMC ecology and evolution2025

Challenging and redefining Dollo's law of evolution: re-appearance of lost structures.

William R Jackman, Vincent J Lynch, Yann Gibert

Abstract readReview
In one paragraph

Review in BMC ecology and evolution, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Loss, persistence and reversal of phenotypic traits.Biological reviews of the Cambridge Philosophical Society · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

William R JackmanBiology Department, Bowdoin College, Brunswick, ME, 04011, USA.
Vincent J LynchDepartment of Biological Sciences, University at Buffalo, SUNY, Buffalo, NY, 14260, USA.
Yann GibertDepartment of Cell and Molecular Biology, Cancer Center and Research Institute, University of Mississippi Medical Center, Jackson, MS, 39216, USA. ygibert@umc.edu.

Funding

The role of leptin in autoimmune-associated hypertensionP20GM104357 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI HALL, JOHN E · 2013 to 2022
$23.4M
NIDCR NIH HHS DE029803NIGMS NIH HHS P20GM0103423NIGMS NIH HHS P20 GM104357
6 · The paper itself

Abstract

According to a modern interpretation of Dollo's Law of irreversibility in evolution, a lost structure, is unable to reappear in evolution due to the accumulation of mutations in the genes required for its formation. However, several reports have challenged this law, even in vertebrates. Lost structures have been reported to re-appear in natural populations, as well as through spontaneous mutations, genetic engineering, and pharmacology. Some of these lost structure re-appearances are fully viable in the organism, especially while others are only detected during embryogenesis or early stages of life as the organism is unable to reach adult stages. We hypothesize that the re-appearance of lost structures can only occur if homologous structures are still fully developed in the organism, allowing for a re-utilization of the developmental pathways that are needed to re-form a lost structure. However, if no instance of the lost character remains, the re-evolution of this specific character cannot happen. Therefore, our latest results using pharmacology continue to support hat has been previously postulated: Dollo's law of evolution remains true for lost characters that have not remained in the organism but should be amended for the re-apparition of lost structures with serial homologous characters present in any form in the organism.

Indexed as

Biological EvolutionVertebratesAnimalsMutationDevelopmental programsDollo’s lawEvoDevoRe-evolutionTooth

Identifiers

PMID40597623
PMCPMC12210513

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.